Literature DB >> 12490610

Presence of diadenosine polyphosphates in the aqueous humor: their effect on intraocular pressure.

Jesús Pintor1, Assumpta Peral, Teresa Peláez, Silvia Martín, Charles H V Hoyle.   

Abstract

Adenine dinucleotides are present in many biological systems and may serve as physiological regulators of processes such as neurotransmitter release, vascular tone or corneal hydration. The presence of diadenosine polyphosphates was investigated in New Zealand White rabbit aqueous humor. Diadenosine tetraphosphate (Ap4A) and diadenosine pentaphosphate (Ap5A) were identified and quantified in the aqueous humor with concentrations of 0.34 +/- 0.1 and 0.08 +/- 0.01 microM, respectively. The effects of topical corneal application of diadenosine pyrophosphate (Ap2A), diadenosine triphosphate (Ap3A), Ap4A, and Ap5A on intraocular pressure in rabbits were also studied. Ap2A, Ap3A, and Ap5A increased intraocular pressure with threshold doses of approximately 0.1 to 1.0 micro g. 10 microl(-1). Ap4A decreased intraocular pressure with an IC50 value of 0.12 micro g. 10 microl(-1) (or 0.13 nmol). Cross-desensitization studies suggested the activation of a P2X receptor for the hypotensive effect of Ap4A and a P2Y receptor in the case of Ap5A. The ATP receptor antagonists (all 100 micro g. 10 microl(-1)), pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid (PPADS), suramin, and reactive blue 2 (RB-2) alone had no effect on intraocular pressure but attenuated responses to diadenosine polyphosphates by approximately 80%. It is concluded that Ap2A, Ap3A, and Ap5A increase intraocular pressure, and Ap4A decreases intraocular pressure via mechanisms that involve P2 receptors, and that Ap4A present in aqueous humor may serve to regulate intraocular pressure. Furthermore, we suggest that topical application of Ap4A to the cornea has therapeutic potential for lowering intraocular pressure, a major risk factor for glaucoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12490610     DOI: 10.1124/jpet.102.041368

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure.

Authors:  Shay Eliahu; Alba Martín-Gil; María Jesús Perez de Lara; Jesús Pintor; Jean Camden; Gary A Weisman; Joanna Lecka; Jean Sévigny; Bilha Fischer
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

2.  Diadenosine tetraphosphate contributes to carbachol-induced tear secretion.

Authors:  Begoña Fonseca; Alejandro Martínez-Águila; Miguel Díaz-Hernández; Jesús Pintor
Journal:  Purinergic Signal       Date:  2014-11-15       Impact factor: 3.765

3.  Light-induced ATP release from the lens.

Authors:  Jesús Pintor
Journal:  Purinergic Signal       Date:  2018-09-20       Impact factor: 3.765

4.  Diadenosine tetraphosphate induces tight junction disassembly thus increasing corneal epithelial permeability.

Authors:  P Loma; A Guzman-Aranguez; M J Pérez de Lara; J Pintor
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

5.  Increased Ap4A levels and ecto-nucleotidase activity in glaucomatous mice retina.

Authors:  María J Pérez de Lara; Ana Guzmán-Aranguez; Rosa Gómez-Villafuertes; Javier Gualix; María Teresa Miras-Portugal; Jesús Pintor
Journal:  Purinergic Signal       Date:  2018-06-08       Impact factor: 3.765

6.  Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma.

Authors:  Begoña Fonseca; Alejandro Martínez-Águila; María J Pérez de Lara; Jesús Pintor
Journal:  Purinergic Signal       Date:  2016-11-16       Impact factor: 3.765

7.  Clinical evaluation of the effect of diquafosol ophthalmic solution in glaucoma patients with dry eye syndrome.

Authors:  Sang Wook Jin; Ji Sang Min
Journal:  Jpn J Ophthalmol       Date:  2016-02-12       Impact factor: 2.447

8.  Diadenosine tetraphosphate (Ap4A) inhibits ATP-induced excitotoxicity: a neuroprotective strategy for traumatic spinal cord injury treatment.

Authors:  David Reigada; Rosa María Navarro-Ruiz; Marcos Javier Caballero-López; Ángela Del Águila; Teresa Muñoz-Galdeano; Rodrigo M Maza; Manuel Nieto-Díaz
Journal:  Purinergic Signal       Date:  2016-10-19       Impact factor: 3.765

Review 9.  Understanding and analyzing meibomian lipids--a review.

Authors:  Igor A Butovich; Thomas J Millar; Bryan M Ham
Journal:  Curr Eye Res       Date:  2008-05       Impact factor: 2.424

10.  Vasospastic individuals demonstrate significant similarity to glaucoma patients as revealed by gene expression profiling in circulating leukocytes.

Authors:  Kristina Yeghiazaryan; Josef Flammer; Selim Orgül; Kerstin Wunderlich; Olga Golubnitschaja
Journal:  Mol Vis       Date:  2009-11-14       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.